Clinical trial
Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Advanced…
NCT00074139 · Case Comprehensive Cancer Center, Other · Withdrawn
Key facts
| NCT number | NCT00074139 |
|---|---|
| Title | Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Advanced Breast Cancer |
| Official title | A Pharmacokinetic Interaction Study Of Docetaxel (Taxotere) 75 mg/mIV On The Combination Therapy Doxorubicin (50 mg/m) And Cyclophosphamide (50 mg/m) In The Treatment Of Advanced Breast Cancer |
| Lead sponsor | Case Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Withdrawn |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | cyclophosphamide, docetaxel, doxorubicin hydrochloride |
| Enrollment | 0 |
| Start date | Sep 1, 2003 |
| Primary completion | Dec 1, 2003 |
| Completion | Dec 1, 2003 |
| First posted | Dec 11, 2003 |
| Last update posted | Mar 5, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: